Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 84.17 |
| Open | 84.30 |
| Bid | 84.43 x 1000 |
| Ask | 84.72 x 1000 |
| Day's Range | 83.98 - 84.95 |
| 52 Week Range | 62.07 - 87.87 |
| Volume | |
| Avg. Volume | 6,548,460 |
| Market Cap | 105.314B |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | 103.16 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.08 (3.64%) |
| Ex-Dividend Date | Sept 13, 2024 |
| 1y Target Est | N/A |
- Simply Wall St.
Gilead Sciences' (NASDAQ:GILD) investors will be pleased with their favorable 62% return over the last five years
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...
- Zacks
Praxis Precision Medicines (PRAX) Moves 8.4% Higher: Will This Strength Last?
Praxis Precision Medicines (PRAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Zacks
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its investigational medicine, lenacapavir, for HIV Prevention.
© 2024 Yahoo. All rights reserved.